Results 111 to 120 of about 2,322 (154)
Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease). [PDF]
Wang QJ, Jung KS, Mohan K, Kleinman ME.
europepmc +1 more source
Autophagic vacuolar myopathy is a common feature of CLN3 disease. [PDF]
Radke J +9 more
europepmc +1 more source
Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis). [PDF]
Augustine EF +8 more
europepmc +1 more source
Longitudinal deep multi-omics profiling in a CLN3<sup>Δex7/8</sup> minipig model identifies biomarker signatures of disease. [PDF]
Rechtzigel MJ +11 more
europepmc +1 more source
PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy. [PDF]
Chandra S, Pahan K.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CLN3, the protein associated with batten disease: Structure, function and localization
Journal of Neuroscience Research, 2005AbstractBatten disease, an inherited neurodegenerative storage disease affecting children, results from the autosomal recessive inheritance of mutations in Cln3. The function of the CLN3 protein remains unknown. A key to understanding the pathology of this devastating disease will be to elucidate the function of CLN3 at the cellular level.
Jill M Weimer, David A Pearce
exaly +3 more sources
Farnesylation of Batten Disease CLN3 Protein
Neuropediatrics, 1997The carboxyl terminal of the predicted amino acid sequence of the Batten disease CLN3 gene protein is CQLS. This motif is expected to be a site for farnesylation at the cysteine residue. In order to determine whether this is indeed farnesylated we have carried out the in-vitro prenylation of tetrapeptides CVLS, CAIL and CQLS using a farnesyl ...
R K, Pullarkat, G N, Morris
openaire +2 more sources

